Abstract:Huntington’s disease (HD) is a fatal neurogenerative disorder caused by an expanded glutamine-coding CAG tract in the Huntingtin (Htt) gene. HD is believed to primarily arise via a toxic gain of function, and as a result a wide range of Htt-lowering treatments are in clinical trials. The safety of these trials is contingent on the risks imposed by Htt lowering: Htt is widely conserved, ubiquitously expressed and its complete loss causes severe developmental symptoms in mice and humans. Recently, multiple labs have reported on the consequences of widespread inducible Htt loss in mice. One report describes that early induction of global Htt loss causes fatal pancreatitis, but that later onset lowering is benign. Another study did not report fatal pancreatitis but suggested that postnatal Htt loss was associated with widespread progressive phenotypes, including subcortical calcification and neurodegeneration. To better understand the risks posed by widespread inducible Htt loss we established the phenotypes of mice in which we knocked out Htt with two tamoxifen inducible Cre lines, which we have here extensively characterized. In short, we find that widespread loss of Htt at 2 months of age leads to a wide range of phenotypes, including subcortical calcification, but does not result in acute pancreatitis or histological changes in the pancreas. Additionally, we report here for the first time that Htt loss is followed by robust and sustained increases in the levels of neurofilament light chain (NfL), a peripherally accessible biomarker of neuroaxonal stress. These results confirm that complete loss of Htt in mice is associated with pronounced risks, including progressive subcortical calcification and neurodegeneration.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is about the safety and potential risks of reducing or completely knocking out Huntingtin (Htt) in the treatment of Huntington's disease (HD). Specifically, the researchers are concerned about whether widespread induction of Htt gene knockout in adult mice will lead to fatal pancreatitis or other serious side effects, and the impact of this knockout on the progression of neurodegenerative diseases. ### Background and Problem Huntington's disease is a fatal neurodegenerative disease caused by abnormal expansion of CAG repeat sequences in the Huntingtin gene (Htt). Since this disease is mainly considered to be caused by a toxic gain - of - function mechanism, reducing or inhibiting the expression of Htt protein has become a potential treatment method. However, the Htt protein has a wide range of functions in cells, and its complete absence may lead to severe developmental disorders or even death. Therefore, it is crucial to understand the safety of widely reducing or knocking out the Htt protein after adulthood. ### Research Objectives 1. **Verify the consistency of previous research results**: Previous studies have reported different results. Some studies have shown that early - induced Htt knockout leads to acute fatal pancreatitis, while others have not observed this phenomenon. This paper aims to verify these inconsistent results by repeating the experiments. 2. **Evaluate the long - term effects after widespread induction of Htt knockout**: The researchers hope to evaluate the pathological changes, especially neurodegenerative lesions and other potential side effects, after widespread induction of Htt knockout in adult mice through long - term observation. 3. **Explore biomarker changes after Htt knockout**: By detecting the level of neurofilament light chain (NfL) in plasma, evaluate the changes in axonal stress after Htt knockout, thereby providing an objective biological indicator to monitor the progression of neurodegenerative diseases. ### Main Findings 1. **No acute fatal pancreatitis was observed**: Different from the report by Wang et al. (2016), no acute fatal pancreatitis caused by early Htt knockout was observed in this study. 2. **Widespread neurodegenerative lesions**: The study found that after widespread induction of Htt knockout in adult mice, progressive neurodegenerative lesions occurred, especially calcified deposits were formed in the thalamus region. 3. **Significantly increased NfL levels**: The NfL level in plasma was significantly increased after Htt knockout, indicating increased axonal stress and further supporting the existence of neurodegenerative lesions. 4. **Behavioral changes**: Mice with Htt knockout showed progressive tremors and movement disorders, and these symptoms gradually worsened over time. ### Conclusion This study confirms that widespread induction of Htt knockout in adult mice will lead to progressive neurodegenerative lesions, but will not cause acute fatal pancreatitis. These findings are of great significance for evaluating the safety and effectiveness of Htt - reducing therapies, suggesting that the degree and method of Htt reduction need to be carefully considered in clinical trials. Future research can further explore more moderate Htt - reducing strategies to reduce potential risks.

Global Huntingtin Knockout in Adult Mice Leads to Fatal Neurodegeneration that Spares the Pancreas

Ablation Of Huntingtin In Adult Neurons Is Nondeleterious But Its Depletion In Young Mice Causes Acute Pancreatitis

Mutant Huntingtin Causes Context-Dependent Neurodegeneration in Mice with Huntington's Disease

N-terminal Huntingtin Knock-In Mice: Implications of Removing the N-terminal Region of Huntingtin for Therapy.

Expression of Mutant Huntingtin in Mouse Brain Astrocytes Causes Age-Dependent Neurological Symptoms

Region-specific pro-survival signaling and global neuronal protection by wild-type Huntingtin

Accumulation of Endogenous Mutant Huntingtin in Astrocytes Exacerbates Neuropathology of Huntington Disease in Mice

Mutant Huntingtin in Glial Cells Exacerbates Neurological Symptoms of Huntington Disease Mice

Developmental and physiological impacts of pathogenic human huntingtin protein in the nervous system

Accumulation of N-terminal Mutant Huntingtin in Mouse and Monkey Models Implicated As a Pathogenic Mechanism in Huntington's Disease

Loss of Hap1 Selectively Promotes Striatal Degeneration in Huntington Disease Mice

Huntingtin and Its Role in Neuronal Degeneration.

N-Terminal Mutant Huntingtin Associates with Mitochondria and Impairs Mitochondrial Trafficking

Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length

Inhibition of Neurite Outgrowth and Promotion of Cell Death by Cytoplasmic Soluble Mutant Huntingtin Stably Transfected in Mouse Neuroblastoma Cells

Ubiquitin-Activating Enzyme Activity Contributes to Differential Accumulation of Mutant Huntingtin in Brain and Peripheral Tissues

A YAC Mouse Model for Huntington’s Disease with Full-Length Mutant Huntingtin, Cytoplasmic Toxicity, and Selective Striatal Neurodegeneration

Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease.

Expression of Mutant N-terminal Huntingtin Fragment (Htt552-100Q) in Astrocytes Suppresses the Secretion of BDNF

A Novel Human Embryonic Stem Cell‐derived Huntington's Disease Neuronal Model Exhibits Mutant Huntingtin (mhtt) Aggregates and Soluble Mhtt‐dependent Neurodegeneration

Alterations in STriatal‐Enriched Protein Tyrosine Phosphatase Expression, Activation, and Downstream Signaling in Early and Late Stages of the YAC128 Huntington's Disease Mouse Model